Get startedLog in
    Picture of Arecor Therapeutics logo

    AREC — Arecor Therapeutics Cashflow Statement

    0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Arecor Therapeutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IFRS
    IFRS
    IFRS    		——
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-6.95-10.5-8.9-10.60.994
    Depreciation
    Amortisation
    Non-Cash Items0.9850.3460.5043.54-3.99
    Discontinued Operations
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital0.339-0.9252.06-2.530.422
    Change in Accounts Receivable
    Change in Inventories
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-5.45-10.8-5.84-9.15-2.36
    Capital Expenditures-0.069-0.345-0.151-0.023-0.099
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items0.001-7.656.671.742.56
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-0.068-7.996.521.722.46
    Financing Cash Flow Items-1.46-0.38-0.015-0.659-0.06
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities20.95.16-0.185.65-0.148
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash15.4-13.60.328-1.85-0.238